Glaucoma Channel
Topics & Medications
Related Channels

Zioptan and Breastfeeding

No human studies have been conducted on breastfeeding and Zioptan (tafluprost), so the full risks of using this drug while breastfeeding are unknown. Although the medication is an eye drop, some of the drug does reach the bloodstream and could potentially pass through breast milk. Before using this medication while nursing, consult your healthcare provider.

Can Breastfeeding Women Use Zioptan?

It is unknown if Zioptan® (tafluprost ophthalmic solution) is safe for use in women who are nursing. If you are breastfeeding or plan to start, you should talk with your healthcare provider before using Zioptan.

More Information on Zioptan and Breastfeeding

Studies have shown that the active ingredient in Zioptan (tafluprost) passes through breast milk in rats. However, no studies have been done to see if the drug passes through human breast milk, or if it would harm a nursing child. Even though Zioptan is an eye drop, some of the medication does reach the bloodstream, where it could potentially pass through breast milk.
If your healthcare provider recommends using Zioptan while breastfeeding, make sure to watch for any side effects in your child.

Talking With Your Healthcare Provider

You should discuss breastfeeding and Zioptan use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
7 Easy Tips for Starting Solids

Zioptan Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.